Thank you to all those that have contributed to the trial and especially to @swasFT and @swasftResearch staff. Even in the face of a cyber attack you have smashed it!😍
It's the last day of @EvadeStudy recruitment! With a predicted recruitment of over 800 participants @swasFT and @swasftResearch have done an amazing job! Still time to use the VAD for your #svt patients and if evidence of benefit we hope the device will continue to be available
Very exciting final stage of @EvadeStudy where by all 100% @swasFT ambulance station clinicians will have access to the Valsalva Assist Device to treat #SVT. Great work by @swasftResearch, @ExeterCTU and @NIHRSW to reach this stage. Approaching 600 patients treated!
bmjopen.bmj.com/content/bmjope… Delighted that our EVADE SVT protocol paper has been published open access. Designing a pragmatic study for delivery during normal ambulance care by usual treating @swasFT clinicians has been challenging and rewarding. @swasftResearch @NIHRSW